Efficacy and Safety of Glucagon‐Like Peptide‐1 Agonists for Psychiatric Symptoms: A Systematic Review

Efficacy and Safety of Glucagon‐Like Peptide‐1 Agonists for Psychiatric Symptoms: A Systematic Review

ABSTRACT Background: Glucagon‐like peptide‐1 receptor agonists (GLP‐1 RAs) have emerged as potential therapeutic options for psychiatric symptoms due to their effects on mood and behavior. However, their use has been primarily for metabolic diseases, and limited research has evaluated their psychiat...

Full description

Saved in:
Bibliographic Details
Main Authors: Shakila Meshkat, Corinna Di Luciano, Alyssa Swiderski, Gloria Li, Reinhard Janssen Aguilar, Benjamin T. Dunkley, Amy C. Reichelt, Yanbo Zhang, Andrew Greenshaw, Eric Vermetten, Rakesh Jetly, Satya Dash, Sri Mahavir Agarwal, Jennifer Swainson, Venkat Bhat
Format: Article
Language:English
Published: Wiley 2025-07-01
Series:Brain and Behavior
Subjects:
depression
glucagon‐like peptide‐1 (GLP‐1) receptor agonists
mental disorders
psychiatric disorders
systematic review
Online Access:https://doi.org/10.1002/brb3.70661
Tags: Add Tag
No Tags, Be the first to tag this record!
Login for hold and recall information

Internet

https://doi.org/10.1002/brb3.70661

Similar Items